Biotechnology Letters

, Volume 16, Issue 6, pp 549–554 | Cite as

Expression of human factor X with normal biological activity in human embryonic kidney cells

  • Deog Joong Kim
  • Harold L. James
Article

Summary

Human embryonic kidney cells (293) were transfected with a construct containing human factor X cDNA and selected for G418 resistance. The level of expression of recombinant factor X in serum-free medium was 4 to 5 μg/ml. Purified recombinant factor X had a molecular size identical to that of normal plasma factor X. Amino-terminal sequencing revealed normal processing cleavages. The γ-carboxy Glu and β-OH Asp content of the recombinant factor X was close to 90% of the expected levels of these post-translational residues. The specific activity of recombinant factor X was about 95% of that of plasma factor X in three plasma-based clotting assays. This report demonstrates that 293 cells can produce a high level of biologically active factor X and describes a visual criterion for verifying the transfection process.

Keywords

Organic Chemistry Biological Activity Active Factor Human Factor Molecular Size 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Abbreviations

FX

factor X

rFX

recombinant factor X

DMEM

Dulbecco's modified Eagle's medium

RVV-X

Russell's viper venom

SDS-PAGE

sodium dodecyl sulfatepolyacrylamide gel electrophoresis

Gla

γ-carboxy glutamic acid

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Chattopadyay A, Fair DS (1989) J.Biol.Chem. 264, 11035–11043Google Scholar
  2. Chem C, Okayama H (1987) Mol.Cell.Biol. 7, 2745–2752Google Scholar
  3. DiScipio RG, Hermodson MA, Yayes SG, Davie EW (1977) Biochemistry 16, 698–706Google Scholar
  4. Fair DS, Plow EF, Edington TS (1979) J.Clin.Invest.64, 884–894Google Scholar
  5. Hamaguchi N, Charifson PS, Pederson LG, Brayer GD, Smith KJ, Stafford DW (1991) J.Biol.Chem. 266, 15213–15220Google Scholar
  6. Jackson CM (1984) Progress in Hemostasis and Thrombosis, vol 7. p 55Google Scholar
  7. Kim DJ, Thompson AR, Nash DR, James HL (1993) Blood 82, 65aGoogle Scholar
  8. Li Zhang, Castellino FJ (1990) Biochemistry 29, 10828–10834Google Scholar
  9. Matsudaira P (1987) J.Biol.Chem. 262, 10035–10038Google Scholar
  10. Price PA (1983) Methods Enzymol. 91, 13–17Google Scholar
  11. Sinha U, Hancock TE, Linj PH, Stan Hollenbach, Wolf DL (1992) Protein Exprerssion and Purification 3, 518–524Google Scholar
  12. Toomey JR, Smith KJ, Stafford DW (1991) J.Biol.Chem. 266, 19198–19202Google Scholar
  13. Wolf DL, Sinha U, Hancock TE, Linj PH, Messier TL, Esmon CT, Church WR (1991) J.Biol.Chem. 266, 13726–13730Google Scholar

Copyright information

© Chapman & Hall 1994

Authors and Affiliations

  • Deog Joong Kim
    • 1
  • Harold L. James
    • 1
  1. 1.Department of BiochemistryThe University of Texas Health Center at TylerTylerUSA

Personalised recommendations